<DOC>
	<DOCNO>NCT02738229</DOCNO>
	<brief_summary>Primary herpetic gingivostomatitis frequent problem pediatrics . Complications dehydration , pain hospitalisation . The objective randomized control trial ass clinical efficacy oral Valacyclovir decrease duration symptom associate acute herpes gingivostomatitis child . This study involve 80 child age 1 8 year old receive weight adjust dos valacyclovir 7 day . The primary outcome measure duration ( day ) feed and/or drinking difficulty .</brief_summary>
	<brief_title>Should We Use Oral Valacyclovir Acute Herpetic Gingivostomatitis Children ?</brief_title>
	<detailed_description />
	<mesh_term>Stomatitis</mesh_term>
	<mesh_term>Stomatitis , Herpetic</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>Inclusion criterion : Children 10 28 Kg weight . The inclusion participant base weight practical/feasibility reason study medication provide tablet format . The low limit 10 kg limit three stratum weight limit cost engender preparation medication . Clinical diagnosis herpetic gingivostomatitis accord treat physician . This described presence : Fever ( &gt; 38.5° rectal , &gt; 38° oral ) AND Vesicular ulcerative lesion locate anterior mouth Associated perioral vesicular lesion Visiting emergency department within first 96 hour disease begin . Exclusion criterion : Duration fever &gt; 4 day Hospitalised patient Immunocompromised patient Patients know hypersensitivity Valacyclovir Patients renal failure Children complete incapacity oral treatment intake Unable contact phone followup</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>